COMBINATION THERAPY EMPLOYING LYMPHOTOXIN BETA RECEPTOR BINDING MOLECULES IN COMBINATION WITH SECOND AGENTS

摘要

This invention features combination therapies that include a composition that activates lymphotoxin-beta receptor signaling in combination with one o r more other biologic agents, as well as therapeutic methods.